Search This Blog

Wednesday, November 6, 2019

Vanda Pharmaceuticals EPS of $1.84

Vanda Pharmaceuticals (NASDAQ:VNDA): Q3 EPS of $1.84 may not be comparable to consensus of $0.07.
Revenue of $59.49M (+21.1% Y/Y) beats by $1.16M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)